Research Highlights: Adults with heart failure who took canagliflozin, a medication originally developed to treat type 2 diabetes, reported improvements in their heart failure ...

Research Highlights: When treated with empagliflozin, adults hospitalized for acute heart failure were 36% more likely to have a clinical benefit, such as a ...

Research Highlights: Adults with chronic, class II or III heart failure with reduced ejection fraction (HFrEF), as defined by the New York Heart Association ...

Research Highlights: Personalized testing may help identify triggers for irregular heart rhythms and reduce their frequency in people with atrial fibrillation. Alcohol consumption ...